PubMed
Oral intake of specific bioactive collagen peptides reduces skin wrinkles and improves dermal matrix synthesis
Proksch et al., 2014
Hydrolyzed Collagen
Oral collagen-derived peptides used for skin, hair, nail, and connective-tissue support.
Overall check-ins
Trackers & reports
Overview
Oral collagen-derived peptides used for skin, hair, nail, and connective-tissue support.
Community
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 100% · Mixed 0% · Unfavorable overall 0%
Benefits users selected when logging a favorable or mixed check-in.
Median bucket: 0–25 mcg · Most common: 0–25 mcg
Reports cluster around 0–25 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Research
PubMed
Proksch et al., 2014
PubMed
García-Coronado et al., 2019
PubMed
Czajka et al., 2018
PubMed
Krečak et al., 2022
Tools
More ways to learn about Collagen Peptides from observational PeptIQ data.
Compare with
Related peptides
Help
This page summarizes 6 anonymized self-reports from PeptIQ users who track Collagen Peptides, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
4 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. Collagen Peptides is listed as Supplement. Consult a licensed clinician for personal medical decisions.
Research, primarily in animal models, suggests Collagen Peptides may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceCollagen Peptides is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Collagen Peptides as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceThe safety and effectiveness of Collagen Peptides have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhile there are over 200 published studies on Collagen Peptides, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source